Topas Therapeutics
PrivateLast Round
Series B
Jul 29, 2021
Total Funding Raised
$110.75M
Company Overview
Topas Therapeutics is a biotechnology company that develops nanoparticle-based therapeutics to induce antigen-specific immune tolerance for the treatment of autoimmune diseases, allergies, and anti-drug antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Topas Therapeutics Comparables
Compare Topas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anokion | 90% | |
| Imcyse | 86% | |
| Cour Pharma | 85% | |
Topas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2021 | ||||
| Series B | Oct 19, 2020 | ||||
| Series A | Nov 2, 2017 | ||||
| Series A | Mar 22, 2016 |
Key People
Founding team and executive leadership
Topas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B |
| Gimv | Series A, Series B |
| Epidarex Capital | Series A, Series B |
| Vesalius Biocapital Partners | Series B |
| Boehringer Ingelheim Venture Fund | Series A, Series B |
| EMBL Ventures | Series A, Series B |
Topas Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Topas Therapeutics's valuation, stock price, and market status.